Neurotrope Inc.
Developing Alzheimer's diagnostic, treatment
This article was originally published in Start Up
Executive Summary
Theories regarding the basis of Alzheimer’s disease have focused primarily on beta-amyloid and tau proteins, but still today no one can say for certain whether these proteins are causative, or merely symptomatic of some other disease process. Neurotrope Inc. is pursuing a new suspect, protein kinase C-epsilon, based on observations that a shortage of PKCe in the brain correlates with erosion of synapses that prevents neurons from functioning properly, and thus leads to loss of neural and motor skills.